Please login to the form below

Not currently logged in
Email:
Password:

The Editors blog

An inside look at what’s happening within the pharma industry and across the PMGroup from the PMLiVE editorial team

Open season?

The EMA's decision to post minutes of CHMP meetings is another step forward for industry transparency

Just as pharma's frontrunners come into view with proposals to substantially advance the clinical trial data debate the EMA moves to address some of its own transparency issues.

The Agency has, for the first time, scraped away some opacity from its inner workings and begun publishing meeting minutes for its Committee for Medicinal Products for Human Use (CHMP). Given that the CHMP, as we well know, issues advice on which products to approve, the move could offer an intriguing glimpse into a previously closed world.

However, the first minutes published leave a little to be desired. Information considered “commercially confidential or sensitive” is “therefore not disclosed”, along with certain, unspecified aspects of on-going CHMP discussions. So whether we should have a positive opinion on the development or request a re-examination remains unclear. 

On a different note I'd like to end this month's comment by introducing the new look PME. We've given our little facelift a lot of thought and, though you'll still find the same vital combination of accessible intelligence within its pages, I hope the design changes will make it that much easier on the eye.

I'd welcome your feedback on the changes – or, for that matter, any aspect of PME – and you can contact me via email on dtyer@pmlive.com.

Article by
Dominic Tyer

editorial director of PMGroup

17th February 2014

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Swordfish Advertising

At Swordfish Advertising, we believe building an effective brand shouldn't be stressful. Don't get us wrong; it takes blood, sweat...

Latest intelligence

EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...
Nudge-nudge, think-think
Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...
Peoples Award
Quality in Care Diabetes 2018: the best in innovative diabetes care
Awards highlight new evidence-based approaches to improving care...

Infographics